Cargando…

Severe hypercalcemia and a pelvic brown tumor in an adolescent with primary hyperparathyroidism: a case report

BACKGROUND: Primary hyperparathyroidism may present in a myriad of manners, varying from an incidental asymptomatic biochemical finding to gastrointestinal, psychiatric, renal, and bone manifestations. While hyperparathyroidism remains a rare diagnosis in the pediatric population, the initial approa...

Descripción completa

Detalles Bibliográficos
Autores principales: Legault, O., Inman, M., Moolman, N., Wiebe, S., Poulin, A., Nour, M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718669/
https://www.ncbi.nlm.nih.gov/pubmed/33278878
http://dx.doi.org/10.1186/s12887-020-02445-7
_version_ 1783619536159768576
author Legault, O.
Inman, M.
Moolman, N.
Wiebe, S.
Poulin, A.
Nour, M. A.
author_facet Legault, O.
Inman, M.
Moolman, N.
Wiebe, S.
Poulin, A.
Nour, M. A.
author_sort Legault, O.
collection PubMed
description BACKGROUND: Primary hyperparathyroidism may present in a myriad of manners, varying from an incidental asymptomatic biochemical finding to gastrointestinal, psychiatric, renal, and bone manifestations. While hyperparathyroidism remains a rare diagnosis in the pediatric population, the initial approach to diagnosis and management of hypercalcemia in children is imperative for the general pediatrician. Herein, we describe an adolescent who presented with a lytic bone lesion and severe, symptomatic hypercalcemia due to primary hyperparathyroidism. CASE PRESENTATION: A 14-year-old male presented with vomiting, constipation, abdominal pain, and lethargy. He had an elevated total corrected calcium of 4.3 mmol/L. He was found to have a large pelvic lytic tumor consistent with a brown tumor due to primary hyperparathyroidism. He received pharmacologic therapy for stabilization of his hypercalcemia, including intravenous saline, intravenous bisphosphonates, and calcitonin. He subsequently received definitive therapy via parathyroidectomy and his post-operative course was complicated by hungry bone syndrome. Long-term follow-up has found full resolution of the lytic lesion and restored calcium homeostasis. CONCLUSIONS: We present this case to highlight the possible presentations of hypercalcemia and hyperparathyroidism that are essential for a general pediatrician to recognize to ensure prompt diagnosis and management. Evaluation for hypercalcemia should be considered in patients with suggestive symptoms and physical exam findings. To our knowledge, this patient represents the first reported pediatric case of a pelvic brown tumor in an adolescent. While the multi-systemic complications of hyperparathyroidism may be quite severe, swift and appropriate management may mitigate these clinical outcomes.
format Online
Article
Text
id pubmed-7718669
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77186692020-12-07 Severe hypercalcemia and a pelvic brown tumor in an adolescent with primary hyperparathyroidism: a case report Legault, O. Inman, M. Moolman, N. Wiebe, S. Poulin, A. Nour, M. A. BMC Pediatr Case Report BACKGROUND: Primary hyperparathyroidism may present in a myriad of manners, varying from an incidental asymptomatic biochemical finding to gastrointestinal, psychiatric, renal, and bone manifestations. While hyperparathyroidism remains a rare diagnosis in the pediatric population, the initial approach to diagnosis and management of hypercalcemia in children is imperative for the general pediatrician. Herein, we describe an adolescent who presented with a lytic bone lesion and severe, symptomatic hypercalcemia due to primary hyperparathyroidism. CASE PRESENTATION: A 14-year-old male presented with vomiting, constipation, abdominal pain, and lethargy. He had an elevated total corrected calcium of 4.3 mmol/L. He was found to have a large pelvic lytic tumor consistent with a brown tumor due to primary hyperparathyroidism. He received pharmacologic therapy for stabilization of his hypercalcemia, including intravenous saline, intravenous bisphosphonates, and calcitonin. He subsequently received definitive therapy via parathyroidectomy and his post-operative course was complicated by hungry bone syndrome. Long-term follow-up has found full resolution of the lytic lesion and restored calcium homeostasis. CONCLUSIONS: We present this case to highlight the possible presentations of hypercalcemia and hyperparathyroidism that are essential for a general pediatrician to recognize to ensure prompt diagnosis and management. Evaluation for hypercalcemia should be considered in patients with suggestive symptoms and physical exam findings. To our knowledge, this patient represents the first reported pediatric case of a pelvic brown tumor in an adolescent. While the multi-systemic complications of hyperparathyroidism may be quite severe, swift and appropriate management may mitigate these clinical outcomes. BioMed Central 2020-12-05 /pmc/articles/PMC7718669/ /pubmed/33278878 http://dx.doi.org/10.1186/s12887-020-02445-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Legault, O.
Inman, M.
Moolman, N.
Wiebe, S.
Poulin, A.
Nour, M. A.
Severe hypercalcemia and a pelvic brown tumor in an adolescent with primary hyperparathyroidism: a case report
title Severe hypercalcemia and a pelvic brown tumor in an adolescent with primary hyperparathyroidism: a case report
title_full Severe hypercalcemia and a pelvic brown tumor in an adolescent with primary hyperparathyroidism: a case report
title_fullStr Severe hypercalcemia and a pelvic brown tumor in an adolescent with primary hyperparathyroidism: a case report
title_full_unstemmed Severe hypercalcemia and a pelvic brown tumor in an adolescent with primary hyperparathyroidism: a case report
title_short Severe hypercalcemia and a pelvic brown tumor in an adolescent with primary hyperparathyroidism: a case report
title_sort severe hypercalcemia and a pelvic brown tumor in an adolescent with primary hyperparathyroidism: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718669/
https://www.ncbi.nlm.nih.gov/pubmed/33278878
http://dx.doi.org/10.1186/s12887-020-02445-7
work_keys_str_mv AT legaulto severehypercalcemiaandapelvicbrowntumorinanadolescentwithprimaryhyperparathyroidismacasereport
AT inmanm severehypercalcemiaandapelvicbrowntumorinanadolescentwithprimaryhyperparathyroidismacasereport
AT moolmann severehypercalcemiaandapelvicbrowntumorinanadolescentwithprimaryhyperparathyroidismacasereport
AT wiebes severehypercalcemiaandapelvicbrowntumorinanadolescentwithprimaryhyperparathyroidismacasereport
AT poulina severehypercalcemiaandapelvicbrowntumorinanadolescentwithprimaryhyperparathyroidismacasereport
AT nourma severehypercalcemiaandapelvicbrowntumorinanadolescentwithprimaryhyperparathyroidismacasereport